Malaria-associated secondary hemophagocytic lymphohistiocytosis: A case report

Table 1 The change in clinical and laboratory manifestations before and after treatment

	Reference range	Before treatment	7 d after treatment	14 d after treatment
Temperature (℃)	36-37	Tmax 39.8	No fever	No fever
White blood cells (× 109/L)	3.50-9.50	2.88	3.78	4.33
Neutrophils (× 109/L)	1.8-6.3	1.31	2.15	2.00
Hemoglobin (g/L)	115-150	49	108	93
Platelet count (× 109/L)	125-350	50	112	151
Reticulocytes (× 1012/L)	0.0140-0.0900	0.1443	0.2269	0.0902
Indirect bilirubin (μmol/L)	0.00-12.00	15.44	16.09	8.59
Triglyceride (mmol/L)	0.57-1.70	2.45	2.42	2.23
Ferritin (ng/mL)	11.00-306.00	1989.00	1730	1516
Fibrinogen (ng/mL)	1.70-4.00	1.41	1.31	1.63
NK-cell activity		Negative		-
sCD25 (pg/mL)		21574		4775
Spleen ultrasonography	Length 8.5 ± 1.0 cm	14.2		-
	Thickness 2.8 ± 0.5 cm	3.8		3.4

sCD25: Soluble CD25; NK cell: Natural killer cell.